ESTABLISHING A NEW BENCHMARK FOR DRUG EVALUATION DURING PREGNANCY

Abstract

The  vast  majority  of  pregnant  women  use medications  either  before  recognizing  they have conceived or later. Yet, very few of these medications have been studied adequately in pregnancy and have been labeled by regulatory agencies for such use. This reality means that very large numbers of women and their unborn babies are at risk of inappropriate and potentially damaging drug therapy